5,852
Views
0
CrossRef citations to date
0
Altmetric
Dermatology

Recognizing skin conditions in patients with cirrhosis: a narrative review

, , , , ORCID Icon, , & ORCID Icon show all
Pages 3016-3028 | Received 11 May 2022, Accepted 18 Oct 2022, Published online: 29 Oct 2022

Abstract

Background: The skin is a major target organ for extrahepatic manifestations of liver diseases, and dermatologic abnormalities are common in patients with hepatic disorders. Clinical examination of the skin, nails and hair can allow for appropriate recognition, early diagnosis and treatment of liver diseases, and improvement in the quality of life and life expectancy of affected patients.

Methods: We searched 3 databases (Pubmed,Medline and Embase) and selected studies about cirrhosis related skin manifestations and their pathophysiology.

Results: A total of 73 articles were included in the review. Studies displayed the spectrum of cutaneous manifestations related to hormonal and vascular changes as well as nail and hair changes in patients with cirrhosis and/or portal hypertension.

Conclusion: Cutaneous alterations are important clues or potential indications in the diagnosis of liver cirrhosis. Familiarity with skin conditions can be promptly diagnosed and appropriate management initiated.

    KEY MESSAGES

  • Manifestations of the liver and skin disorders are interrelated in various ways. Cutaneous changes may be the first clue that a patient has liver disease.

  • The skin is a major target organ for extrahepatic manifestations of liver diseases. A broad range of cutaneous alterations can be present in patients with cirrhosis, such as vascular, nail, hair, hormonal changes, etc.

  • Recognizing these signs is crucial so that potential underlying diseases including liver disease can be promptly diagnosed and appropriate management timely initiated.

Introduction

The liver is the second largest organ in the body and is involved in carbohydrate, protein, lipid homeostasis, bile production and storage and filtration of blood [Citation1]. Liver impairment affects almost all body systems, and skin manifestations are common and sometimes the most noticeable aspect of the physical examination and/or symptoms. The majority of cutaneous conditions are asymptomatic requiring no specific therapy, but the diagnosis of cutaneous conditions can often help unmask undiagnosed liver disease and facilitate earlier treatment. Despite modern technological advances, physical examination by a care provider remains the cornerstone of medical diagnosis and management.

Efficient and timely bedside diagnosis of chronic liver disease, especially cirrhosis is particularly relevant, as cirrhosis is the eleventh most common cause of death globally according to a recent report in 2019 [Citation2,Citation3]. In the US, an increase in cirrhosis incidence is also associated with increased mortality, hospitalization and cost in the past decade [Citation4–6].

Therefore, general practitioners as well as hepatology and dermatology specialists should be familiar with cutaneous manifestations of liver disease to facilitate early diagnosis and treatment of liver cirrhosis. In this synopsis, we reviewed the association between hormonal, vascular, nail and hair changes as well as other cutaneous manifestations related to liver disease, focusing on cirrhosis and/or portal hypertension. We will also review the pathophysiologic mechanism underlying these cutaneous conditions in patients with cirrhosis and/or portal hypertension, relevant differential diagnoses () and management.

Table 1. Dermatologic vascular manifestations associated with liver and non-liver conditions.

Table 2. Nail changes associated with liver and non-liver conditions.

Table 3. Hair, hormonal and other changes associated with liver and non-liver conditions.

Ethical approval and considerations

This study was carried out in accordance with the International Conference on Good Clinical Practice Standards and the Declaration of Helsinki, and was approved by the Institutional Review Board of The Second Affiliated Hospital of Xi’an Jiaotong University (2018059; Shaanxi, China). The authors obtained written informed consent from all participants in the study. And all participants agreed to publish their de-identified image data.

Vascular alterations

Hemodynamic changes and palmar erythema

Liver cirrhosis is characterized by splanchnic and peripheral vasodilation, hyperdynamic circulation and local differences in peripheral circulation between the upper and lower limbs as well as the torso, and these hemodynamic differences predispose to the development of skin vascular abnormalities, including spider veins, palmar erythema and warm hands [Citation7–9].

Palmar erythema (), also known as liver palms, is characterized by capillary dilatation in the skin of the thenar eminence and fingertips and manifested by blanchable redness of the skin. This condition is caused by elevated serum oestrogen levels and changes in peripheral hemodynamics [Citation8,Citation10]. Though palmar erythema occurs in about two-thirds of patients with liver cirrhosis [Citation10], it is non-specific and can also occur in patients with rheumatoid arthritis, hyperthyroidism, diabetes, juvenile dermatomyositis and pregnancy [Citation10,Citation11].

Figure 1. Vascular alterations in patients with chronic liver disease. (a) Palmar erythema, (b, c) Spider angioma, (d) Arteriovenous haemangioma, (e, f) arteriovenous haemangioma on the upper lip of a 38-year-old cirrhotic male with HBV infection, with remission after 10 years of antiviral treatment. (g) Paper money skin, (h) caput medusa, (i) abdominal varicose veins in inferior vena cava obstruction syndrome.

Figure 1. Vascular alterations in patients with chronic liver disease. (a) Palmar erythema, (b, c) Spider angioma, (d) Arteriovenous haemangioma, (e, f) arteriovenous haemangioma on the upper lip of a 38-year-old cirrhotic male with HBV infection, with remission after 10 years of antiviral treatment. (g) Paper money skin, (h) caput medusa, (i) abdominal varicose veins in inferior vena cava obstruction syndrome.

Spider angioma

Spider angioma () is a small telangiectatic lesion consisting of a central arteriole from which capillaries radiate peripherally [Citation12]. This entity occurs in 10–15% of healthy individuals, especially adolescents, pregnant women and women who use oestrogen for contraception. However, when multiple spider angiomas appear, they may be a skin manifestation of liver disease, especially alcoholic cirrhosis and hepatopulmonary syndrome [Citation13,Citation14]. Approximately 33% of patients with liver cirrhosis have spider angiomas [Citation15]. Spider angiomas usually range from a few millimetres to a few centimetres in diameter. These lesions are commonly observed in the area of the superior vena cava above the line joining the nipples [Citation13,Citation15]. Spider angiomas localized on the nose () should be differentiated from erythematotelangiectatic rosacea (ETTR). In contrast to painless spider angiomas, ETTR leads to sensitive skin prone to irritation upon contact with skin care products [Citation16].

Younger age as well as increased levels of vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) were also found to be independent predictors of spider naevus in patients with liver cirrhosis [Citation17]. The high incidence of spider angiomas in patients with alcoholic liver cirrhosis may occur because ethanol induces VEGF expression and promotes angiogenesis [Citation13,Citation18].

Arteriovenous haemangioma

Arteriovenous haemangiomas (AVH) () are benign and acquired vascular tumours characterized by bluish erythematous papules or nodules with a diameter of 0.5–1.0 cm. Lesions present as single erythematous plaques in the head and neck in most cases and are more prevalent in middle-aged men [Citation19], which can regress as liver function improves (). Histopathological features include well-circumscribed dome-shaped lesions in the upper and mid-reticular dermis with dilated thick- and thin-walled endothelium-lined spaces resembling arteries and veins, respectively. In addition, there are also a small number of inflammatory cells infiltrating interstitial cells, while elastic staining indicates the absence of an internal elastic lamina in these vessels, suggesting the dominance of the venous components [Citation20]. The mechanism of AVH is unclear and may be related to elevated oestrogen levels, though Lee et al. found no oestrogen receptors in the biopsy of AVH in patients with liver cirrhosis [Citation19].

Paper money skin

Paper money skin () is an atypical spider angioma, which manifests as numerous threadlike small blood vessels scattered randomly throughout the skin and disappears under pressure. The distribution is similar to spider angiomas. Lesions are commonly found in the neck, upper torso and upper limbs and resemble security threads on paper money. The mechanism is the same as that of spider angioma [Citation21].

Caput medusa

Severe portal hypertension of various aetiologies including cirrhosis promotes collateral circulation leading to oesophageal, gastric, abdominal and rectal varices. Abdominal varicose veins can be manifested in the superficial veins of the chest and abdomen presenting a net shape, or abdominal veins with obvious varicose beads or masses. Severe abdominal varicose veins appear as distended veins that radiate from the umbilicus across the abdominal wall resembling a ‘caput medusa’ because the affected veins resemble the snake-like hair of Medusa, a gorgon from Greek mythology () [Citation22].

Caput medusa should be differentiated from vena cava obstruction syndrome (). In the latter, abdominal varicose veins are located on the right or bilateral abdomen [Citation23]. The blood flow direction of the abdominal varicose veins of the superior vena cava obstruction syndrome is from top to bottom, and that of the inferior vena cava obstruction syndrome is from bottom to top [Citation24].

Superficial abdominal varicose veins are usually asymptomatic and are found during physical examination or abdominal imaging in patients with advanced liver cirrhosis. However, cases of severe superficial abdominal variceal bleeding have been reported in the literature [Citation25]. Local treatment, such as pressure dressings or sutures, may temporarily control bleeding, but it recurs easily due to unrelieved portal hypertension. Transjugular intrahepatic portosystemic shunt (TIPS) may be effective in treating abdominal variceal haemorrhage and reduces the recurrence rate [Citation26,Citation27].

Nail changes

Nail abnormalities are also common among patients with liver diseases. Salem et al. found that nail changes occurred in 68% of patients with chronic liver diseases [Citation28]. The most common abnormalities were onychomycosis and longitudinal striations, but several other nail changes are also associated with liver cirrhosis and will be reviewed below. Although non-specific in most cases, nail changes can help provide diagnostic clues to liver cirrhosis.

Terry’s nails

Terry’s nails () are characterized by the presence of a white nail bed, a distal brown to pink transverse band of 0.5–2.0 mm in width, and the absence of lunulae [Citation29–31]. First reported by Terry in 1954, this condition is a cardinal sign of hepatic cirrhosis [Citation29,Citation32]. However, Holzberg and Walker found a strong correlation between Terry’s nails and congestive heart failure as well as adult-onset diabetes mellitus in addition to cirrhosis in their study of 512 hospitalized patients [Citation33]. Hyperthyroidism, malnutrition, renal failure and Reiter syndrome have also been associated with Terry’s nails [Citation15,Citation34]. In addition, Terry’s nails are associated with ageing in populations without known systemic diseases [Citation33].

Figure 2. Nail changes in patients with chronic liver disease. (a–c) Terry’s nails, (d) Lindsay’s nails, (e) leukonychia, (g) clubbing nails, (f) onycholysis, (h) brittle nails, (i) longitudinal striations, (j) koilonychia, (k, l) onychomycosis.

Figure 2. Nail changes in patients with chronic liver disease. (a–c) Terry’s nails, (d) Lindsay’s nails, (e) leukonychia, (g) clubbing nails, (f) onycholysis, (h) brittle nails, (i) longitudinal striations, (j) koilonychia, (k, l) onychomycosis.

The pathogenesis of Terry’s nails is poorly understood but is thought to be related to telangiectasia [Citation33]. Meanwhile, Lindsay’s nails (), the most common differential diagnosis of Terry’s nails, are characterized by the distal extension of the lunula and a pink or reddish-brown distal transverse band, and this condition is closely linked to chronic renal diseases [Citation35].

Muehrcke’s nail

Muehrcke’s nail is a type of leukonychia in which the second, third and fourth fingernails have one or more pale transverse white bands across the nail plate, parallel to the lunula, which disappear on pressure [Citation36]. This condition indicates hypoalbuminemia secondary to cirrhosis, nephrotic syndrome, pellagra and sprue and can resolve by increasing serum levels of albumin [Citation37]. Muehrcke’s lines constitute an abnormality of the vascular nail bed that does not shift as the nails grow [Citation38]. This abnormality is also associated with chemotherapy [Citation39,Citation40].

Leukonychia

Leukonychia (), or whitening of the nail plate, also known as ongchostoma sima, is a common disease that was first described in 1919. Leukonychia is classified as acquired or congenital and may be due to an abnormality of the nail bed (pseudoleukonychia) or nail plate (true leukonychia) [Citation41]. True leukonychia showed diffuse ground glass opacity and white colour of the nail bed, which was different from Terry’s nail in that there was no distal pink or brown band.

Red and blue lunula

Red lunula refers to the blanchable red discolouration of the lunula and occurs in patients with cirrhosis, cardiac failure, systemic lupus erythematosus, chronic urticaria, psoriasis and carbon monoxide poisoning [Citation42]. The azure lunula is the blue discolouration of the lunula that occurs in Wilson’s disease, a hereditary disorder of copper metabolism [Citation43].

Clubbing and hypertrophic osteoarthropathy

Clubbing () is the incrassation of the soft organization beneath the proximal nail plate, leading to increased curvature of the nails. Diagnostic findings include Lovibond’s angle, and the Schamroth sign [Citation44]. This condition may indicate cyanotic congenital heart disease, pulmonary fibrosis, bronchial carcinoma, inflammatory bowel disease, cirrhosis and thyroid acropachy. Although the underlying mechanism remains elusive, several hypotheses have been proposed, including neurocirculatory reflex, growth hormone and megakaryocyte/platelet clump [Citation45]. It is important to differentiate between clubbing and hypertrophic osteoarthropathy, which may resemble clubbing but is distinguished from clubbing by the presence of a painful nail bed, while clubbing is asymptomatic. Hypertrophic osteoarthropathy is associated with the paraneoplastic syndrome of several malignancies, including primary liver cancer [Citation46].

Onycholysis

Onycholysis () is the detachment of the nail bed from the overlying nail plate and may be due to trauma, manicuring and photodermatitis. While psoriasis is the most prevalent disease leading to onycholysis [Citation47], there is also a significant association between liver cirrhosis and onycholysis, which have been reported to resolution following liver transplant [Citation48].

Brittle nail syndrome

Brittle nail syndrome () is characterized by increased fragility of the nail plate. The main clinical features are onychoschizia, onychorrhexis, superficial granulation of keratin and worn-down nail. This condition affects up to 20% of the population, especially women over 50 years of age. Brittle nails can be either inherited or acquired and are associated with systemic diseases including liver cirrhosis, drug therapy, nutritional deficiencies, trauma, infections and nail dehydration [Citation49,Citation50].

Longitudinal striations

Longitudinal striations () are embossed crista on the nail surface, accompanied by nail thinning and fracture. The presence of longitudinal striations is a common form of nail dystrophy, which is caused by a deficiency in vitamins and calcium. The condition is termed 20-nail dystrophy in cases involving all nails [Citation40,Citation51].

Koilonychia

Koilonychia () (spoon-shaped nails) is a disorder in which nail plates are concave centrally and raised laterally. Water droplets can converge on the hollow nail plate and can serve as a useful diagnostic tool [Citation52]. Chinazzo et al. performed a prospective observational study and found that the prevalence of koilonychia in healthy newborns was 32.7% [Citation53]. While the abnormality is a natural variant, it is associated with iron deficiency anaemia, hemochromatosis, coronary disease, hypothyroidism and cirrhosis, giving diagnostic clues to these conditions when present in an appropriate context [Citation43].

Onychomycosis

Onychomycosis () is a common nail disease caused by dermatophytes, nondermatophytes and yeast. Clinical manifestations include nail discolouration, nail separation, brittleness and thickening that may worsen over time. It may cause local pain, paresthaesia, difficulty performing activities of daily living, and social isolation. Predisposing factors include trauma, senility, tinea pedis, diabetes, immunosuppression and cirrhosis [Citation54,Citation55]. The prevalence of onychomycosis in primary biliary cholangitis (PBC) patients is as high as 49% [Citation55,Citation56].

Hair and hormonal changes

Chronic liver diseases, especially end-stage liver disease such as decompensated cirrhosis, are associated with loss of axillary, arm and pubic hair (). In men, liver cirrhosis is linked with a decrease in the growth rate of facial hair, female pubic hair pattern, loss of libido, testicular atrophy, oligospermia and gynaecomastia (). Gynaecomastia is the first symptom of liver cirrhosis in some cases and should be differentiated from the gynaecomastia induced by hormone therapy for prostate cancer [Citation57,Citation58]. Commonly-used medications in patients with cirrhosis and ascites such as spironolactone can exacerbate symptoms of gynaecomastia and an alternate dose or therapy may be required [Citation59].

Figure 3. Hair, hormonal and other dermatologic manifestations in patients with chronic liver disease. (a) Loss of pubic hair, (b) gynaecomastia, (c) jaundice, (d) prurigo nodularis, (e) xanthelasmas, (f–h) pigmentation, (i) leg ulcer.

Figure 3. Hair, hormonal and other dermatologic manifestations in patients with chronic liver disease. (a) Loss of pubic hair, (b) gynaecomastia, (c) jaundice, (d) prurigo nodularis, (e) xanthelasmas, (f–h) pigmentation, (i) leg ulcer.

Other dermatologic manifestations

Jaundice

Jaundice () describes discolouration of the skin, sclera and mucous membranes that is attributable to the accumulation of bilirubin and its metabolites in the tissues. Jaundice generally begins to become visible when the concentration of serum bilirubin surpasses about 2 mg/dL (34 mmol/L). The colour of the skin varies from lemon yellow to apple green, gradually evolving as the serum bilirubin level becomes elevated. According to the presence of conjugated or unconjugated components of bilirubin, we can classify the three major groups of underlying causes of jaundice: prehepatic, intrahepatic or post-hepatic. Prehepatic jaundice involves haemolytic anemias, which can also be seen in neonatal physiological jaundice and breast milk jaundice. Intrahepatic jaundice involves both conjugated and unconjugated hyperbilirubinemia resulting from liver failure-associated severe acute hepatitis or cirrhosis. Other intrahepatic causes of hyperbilirubinemia include intrahepatic cholestatic diseases, such as PBC and the various congenital genetic disorders involving bilirubin metabolism or transport such as Gilbert, Crigler–Najjar syndrome, or Dubin-Johnson syndrome. Post-hepatic jaundice involves conjugated hyperbilirubinemia arising from extrahepatic issues, such as biliary tract obstruction [Citation1].

Pruritus

Pruritus is a sensation that induces persistent or intermittent itching and involuntary scratching. It can affect the whole body or be confined to the limbs, especially the footplate and palm, where more intensive itchiness may occur. It is one of the most common skin abnormalities that occur in liver disease, particularly in patients with cholestatic liver disease. As a frequent concomitant symptom without visible lesions of liver cirrhosis, pruritus is usually linked to cholestasis in PBC, primary sclerosing cholangitis, obstructive gallstone disease and carcinoma of the bile duct. It can also be the most prominent symptom in certain pregnancy-associated liver conditions such as intrahepatic cholestasis of pregnancy [Citation60]. Viral hepatitis-related cirrhosis can lead to intense pruritus, accompanied by solid crusty nodules, which are called prurigo nodularis (). Usually distributed in the extremities, especially between the knee and ankle and forearm, the lesion is associated with the topical deposition of an immune complex consisting of HBV/HCV in the skin [Citation1]. Data from a large cohort of patients with chronic liver disease (n = 1631) suggest that the overall prevalence of pruritus was about 40% overall, higher among those with cirrhosis and as high as 50% in those with PBC and 60% in those with autoimmune overlap syndrome [Citation61].

Pruritus may be intermittent and minimally symptomatic but when persistent can lead to a dramatic reduction in quality of life, insomnia, depression and even suicidal attempts. The intensity or pruritus appears to follow a nyctohemeral rhythm, being most severe in the late evening [Citation62,Citation63]. While the health-related quality of life and severity of pruritus appears to be exacerbated by the presence of advanced diseases such as cirrhosis, the ailment development in PBC is not linked to the severity of pruritus [Citation64,Citation65].

The pathogenesis of pruritus in cholestasis is complicated and obscure. Bile salts, endogenous opioids, serotonin, progesterone metabolites and lysophosphatidic acid have all been considered contributory factors [Citation66]. However, the precise role of this substance is unclear due to the lack of an observed relation between concentrations of these molecules and the intensity of the pruritus. Lysophosphatidic acid (commonly referred to as LPA), produced by the enzyme autotaxin (ATX), has also been characterized as an underlying pruritogen in cholestasis. ATX activity and serum LPA levels correlate with the severity of pruritus, suggesting the potential role of each as therapeutic target [Citation67].

Xanthelasmas or xanthomas

Xanthelasma () manifests as pale yellow, planar or slightly bulged, soft plaques around the eyelids, being essentially subcutaneous lipid deposits. The condition is associated with dyslipoproteinaemia secondary to liver diseases such as PBC and other forms of cholestatic liver disease. The condition is seen most frequently in females over 50 years old, and half of the cases present with comorbid dyslipidemia. Xanthelasmas associated with the autosomal dominant form of hereditary hypercholesterolaemia develop during childhood and the clinical profile includes xanthelasma, tendon xanthoma, increased low-density lipoprotein, arcus corneae and premature coronary artery disease [Citation68]. One case of regression has been reported after liver transplantation in a patient with PBC [Citation69].

Pigmentation

Patients with cirrhosis usually have abnormal pigmentation. The pigmentation on the face is manifested by a muddy gray complexion, called hepatic face (), which is induced by hormone metabolism turbulence. Pigmentation can also occur in terminals of the extremities (), presenting with black discolouration, especially common in patients with cirrhosis. When occurring in the tibial anterior (), pigmentation is caused by the extravasation of red blood cells and deposition of hemosiderin due to lower extremity edoema and obstruction of venous reflux [Citation70].

Leg ulcer

Leg ulcer () appears as a lesion in which necrotic tissue adheres to the basilar part and the edge is raised, often occurring on the tibial anterior. It is related to hypoxia-ischemia induced by lower extremity edoema and obstruction of venous reflux.

Coagulation defects

Cirrhosis is considered to be a thrombosis-prone state because venous stasis from portal hypertension and the inflammatory milieu promote the development of portal vein thrombosis [Citation71]. However, coagulation defects can also be observed in cirrhosis [Citation72,Citation73]. In patients with cirrhosis, coagulation defects manifest as skin petechiae, ecchymosis, or mucosal bleeding, the causes being complex and multiple. Cirrhosis and portal hypertension are often marked with thrombocytopenia. While patients with cirrhosis typically have platelet counts adequate for the production of thrombin at a level equivalent to the rock bottom of the normal extent in a healthy population, the balance of fibrinolysis may be altered by acute events such as infection leading to hyperfibrinolysis, which increases the risk of haemorrhage. Moreover, in patients with cirrhosis, protein synthesis often is diminished, leading to a dramatic reduction in most factors and inhibitors of clotting and fibrinolytic systems, leading to further coagulation defects [Citation72,Citation73].

Conclusions

A broad range of cutaneous alterations can be present in patients with liver cirrhosis, portal hypertension and other chronic liver diseases. Vascular changes in the upper part of the body are important clues in the diagnosis of liver cirrhosis, and toenail changes and other skin signs may indicate potential chronic liver diseases, especially liver cirrhosis. While the majority of these cutaneous conditions are asymptomatic, some may require specific therapy, such as pruritus and all should be recognized as signs of potential underlying diseases, including liver cirrhosis, so that underlying conditions can be promptly diagnosed and appropriate management initiated.

Author contributions

Conception and design: Y.L., Y.Z., F.J., Z.L. and M.H.N.; literature search and investigation: Y.L., Y.Z., X.G. and L.J.; writing-original draft: Y.L., Y.Z. and F.J.; writing-review and editing: F.J., Y.H., Z.L. and M.H.N.

Disclosure statement

No potential conflict of interest was reported by all the authors. All authors agree to be accountable for all aspects of the work. The funding source had no involvement in writing the report.

Data availability statement

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Additional information

Funding

This report was funded by the National Natural Science Foundation of China [81773327, 82170626]; Excellent Series of Teaching Materials for Graduate Students of Xi’an Jiaotong University in the ‘14th 5-year Plan’ [JC2020-10120].

References

  • Hazin R, Abu-Rajab Tamimi TI, Abuzetun JY, et al. Recognizing and treating cutaneous signs of liver disease. Cleve Clin J Med. 2009;76(10):599–606.
  • Asrani SK, Devarbhavi H, Eaton J, et al. Burden of liver diseases in the world. J Hepatol. 2019;70(1):151–171.
  • Heron M. Deaths: leading causes for 2017. Natl Vital Stat Rep. 2019;68(6):1–77.
  • Tapper EB, Parikh ND. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study. BMJ. 2018;362:k2817.
  • Beste LA, Leipertz SL, Green PK, et al. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001-2013. Gastroenterology. 2015;149(6):1471–1482.
  • Zou B, Yeo YH, Jeong D, et al. A nationwide study of inpatient admissions, mortality, and costs for patients with cirrhosis from 2005 to 2015 in the USA. Dig Dis Sci. 2020;65(5):1520–1528.
  • Møller S, Bendtsen F. The pathophysiology of arterial vasodilatation and hyperdynamic circulation in cirrhosis. Liver Int. 2018;38(4):570–580.
  • Okumura H, Aramaki T, Katsuta Y, et al. Regional differences in peripheral circulation between upper and lower extremity in patients with cirrhosis. Scand J Gastroenterol. 1990;25(9):883–889.
  • Steele JD, Dillon JF, Plevris JN, et al. Hand skin temperature changes in patients with chronic liver disease. J Hepatol. 1994;21(6):927–933.
  • Serrao R, Zirwas M, English JC. Palmar erythema. Am J Clin Dermatol. 2007;8(6):347–356.
  • Amoroso S, Pastore S, Tommasini A, et al. Palmar erythema: a diagnostic clue of juvenile dermatomyositis. J Paediatr Child Health. 2020;56(7):1159.
  • Li CP, Lee FY, Hwang SJ, et al. Role of substance P in the pathogenesis of spider angiomas in patients with nonalcoholic liver cirrhosis. Am J Gastroenterol. 1999;94(2):502–507.
  • Li CP, Lee FY, Hwang SJ, et al. Spider angiomas in patients with liver cirrhosis: role of alcoholism and impaired liver function. Scand J Gastroenterol. 1999;34(5):520–523.
  • Silvério AdO, Guimarães DC, Elias LFQ, et al. Are the spider angiomas skin markers of hepatopulmonary syndrome? Arq Gastroenterol. 2013;50(3):175–179.
  • Ghosn SH, Kibbi AG. Cutaneous manifestations of liver diseases. Clin Dermatol. 2008;26(3):274–282.
  • Yigider AP, Kayhan FT, Yigit O, et al. Skin diseases of the nose. Am J Rhinol Allergy. 2016;30(3):83–90.
  • Li CP, Lee FY, Hwang SJ, et al. Spider angiomas in patients with liver cirrhosis: role of vascular endothelial growth factor and basic fibroblast growth factor. World J Gastroenterol. 2003;9(12):2832–2835.
  • Gu JW, Elam J, Sartin A, et al. Moderate levels of ethanol induce expression of vascular endothelial growth factor and stimulate angiogenesis. Am J Physiol Regul Integr Comp Physiol. 2001;281(1):R365–R372.
  • Lee HW, Yun WJ, Choi JC, et al. Arteriovenous haemangioma in chronic liver diseases: case report and determination of oestrogen receptor status. J Eur Acad Dermatol Venereol. 2006;20(7):884–885.
  • Akiyama M, Inamoto N. Arteriovenous haemangioma in chronic liver disease: clinical and histopathological features of four cases. Br J Dermatol. 2001;144(3):604–609.
  • Smith KE, Fenske NA. Cutaneous manifestations of alcohol abuse. J Am Acad Dermatol. 2000;43(1):1–16.
  • Li T, Zhi XT, Hu SY. Congenital portal venous system aneurysms associated with caput medusae. Hepatology. 2011;53(3):1052–1053.
  • Qi X, Han G. Images in clinical medicine. Abdominal-wall varices in the Budd-Chiari syndrome. N Engl J Med. 2014;370(19):1829.
  • Philips CA, Arora A, Shetty R, et al. A comprehensive review of portosystemic collaterals in cirrhosis: historical aspects, anatomy, and classifications. Int J Hepatol. 2016;2016:6170243.
  • Chen PT, Tzeng HL, Wang HP, et al. Caput medusae bleeding. Am J Gastroenterol. 2020;115(10):1570.
  • Sze DY, Magsamen KE, McClenathan JH, et al. Portal hypertensive hemorrhage from a left gastroepiploic vein caput medusa in an adhesed umbilical hernia. J Vasc Interv Radiol. 2005;16(2):281–285.
  • Strauss C, Sivakkolunthu M, Ayantunde AA. Recurrent and troublesome variceal bleeding from parastomal caput medusae. Korean J Gastroenterol. 2014;64(5):290–293.
  • Salem A, Gamil H, Hamed M, et al. Nail changes in patients with liver disease. J Eur Acad Dermatol Venereol. 2010;24(6):649–654.
  • Terry R. White nails in hepatic cirrhosis. Lancet. 1954;266(6815):757–759.
  • Nia AM, Ederer S, Dahlem KM, et al. Terry’s nails: a window to systemic diseases. Am J Med. 2011;124(7):602–604.
  • Li Z, Ji F, Deng H. Terry’s nails. Braz J Infect Dis. 2012;16(3):311–312.
  • Nelson N, Hayfron K, Diaz A, et al. Terry’s nails: clinical correlations in adult outpatients. J Gen Intern Med. 2018;33(7):1018–1019.
  • Holzberg M, Walker HK. Terry’s nails: revised definition and new correlations. Lancet. 1984;1(8382):896–899.
  • Coskun BK, Saral Y, Ozturk P, et al. Reiter syndrome accompanied by terry nail. J Eur Acad Dermatol Venereol. 2005;19(1):87–89.
  • Pitukweerakul S, Pilla S. Terry’s nails and Lindsay’s nails: two nail abnormalities in chronic systemic diseases. J Gen Intern Med. 2016;31(8):970.
  • Sharma V, Kumar V. Muehrcke lines. Canadian Med Assoc J. 2013;185(5):E239.
  • Kozaru T, Fukumoto T, Shirai T, et al. Muehrcke lines on fingers and toenails. Eur J Dermatol. 2019;29(1):87–88.
  • Fawcett RS, Linford S, Stulberg DL. Nail abnormalities: clues to systemic disease. Am Fam Physician. 2004;69:1417–1424.
  • Chen W, Yu YS, Liu YH, et al. Nail changes associated with chemotherapy in children. J Eur Acad Dermatol Venereol. 2007;21(2):186–190.
  • Chang X, Zhen P, Zeng J. Fingernails changes associated with chemotherapy in breast cancer: Muehrcke’s lines. Clin Case Rep. 2018;6(8):1653–1654.
  • Ates D, Kosemehmetoglu K. Acquired leukonychia of the distal nail plate: a morphologic and proteomic analysis. Am J Dermatopathol. 2020;42(4):261–264.
  • Wilkerson MG, Wilkin JK. Red lunulae revisited: a clinical and histopathologic examination. J Am Acad Dermatol. 1989;20(3):453–457.
  • Dzieżyc-Jaworska K, Litwin T, Członkowska A. Clinical manifestations of Wilson disease in organs other than the liver and brain. Ann Transl Med. 2019;7(2):S62.
  • Gregoriou S, Argyriou G, Larios G, et al. Nail disorders and systemic disease: what the nails tell us. J Fam Pract. 2008;57(8):509–514.
  • Spicknall KE, Zirwas MJ, English JC. 3rd. Clubbing: an update on diagnosis, differential diagnosis, pathophysiology, and clinical relevance. J Am Acad Dermatol. 2005;52(6):1020–1028.
  • Callemeyn J, Van Haecke P, Peetermans WE, et al. Clubbing and hypertrophic osteoarthropathy: insights in diagnosis, pathophysiology, and clinical significance. Acta Clin Belg. 2016;71(3):123–130.
  • Zaias N, Escovar SX, Zaiac MN. Finger and toenail onycholysis. J Eur Acad Dermatol Venereol. 2015;29(5):848–853.
  • Gandhi V, Nagral A, Philip S, et al. Reversal of nail changes after liver transplantation in a child. Indian J Gastroenterol. 2009;28(4):154–156.
  • Chessa MA, Iorizzo M, Richert B, et al. Pathogenesis, clinical signs and treatment recommendations in brittle nails: a review. Dermatol Ther. 2020;10(1):15–27.
  • van de Kerkhof PC, Pasch MC, Scher RK, et al. Brittle nail syndrome: a pathogenesis-based approach with a proposed grading system. J Am Acad Dermatol. 2005;53(4):644–651.
  • Solak B, Acikgoz SB, Sipahi S, et al. Cutaneuos findings in patients with predialysis chronic kidney disease. J Eur Acad Dermatol Venereol. 2016;30(9):1609–1613.
  • Walker J, Baran R, Vélez N, et al. Koilonychia: an update on pathophysiology, differential diagnosis and clinical relevance. J Eur Acad Dermatol Venereol. 2016;30(11):1985–1991.
  • Chinazzo M, Lorette G, Baran R, et al. Nail features in healthy term newborns: a single-Centre observational study of 52 cases. J Eur Acad Dermatol Venereol. 2017;31(2):371–375.
  • Gupta AK, Versteeg SG, Shear NH. Onychomycosis in the 21st century: an update on diagnosis, epidemiology, and treatment. J Cutan Med Surg. 2017;21(6):525–539.
  • Lipner SR, Scher RK. Onychomycosis: clinical overview and diagnosis. J Am Acad Dermatol. 2019;80(4):835–851.
  • Koulentaki M, Ioannidou D, Stefanidou M, et al. Dermatological manifestations in primary biliary cirrhosis patients: a case control study. Am J Gastroenterol. 2006;101(3):541–546.
  • Michalopoulos NV, Keshtgar MR. Images in clinical medicine. Gynecomastia induced by prostate-cancer treatment. N Engl J Med. 2012;367(15):1449.
  • Neong SF, Billington EO, Congly SE. Sexual dysfunction and sex hormone abnormalities in patients with cirrhosis: review of pathogenesis and management. Hepatology. 2019;69(6):2683–2695.
  • Sehgal R, Singh H, Singh IP. Comparative study of spironolactone and eplerenone in management of ascites in patients of cirrhosis of liver. Eur J Gastroenterol Hepatol. 2020;32(4):535–539.
  • Glantz A, Reilly SJ, Benthin L, et al. Intrahepatic cholestasis of pregnancy: amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine. Hepatology. 2008;47(2):544–551.
  • Oeda S, Takahashi H, Yoshida H, et al. Prevalence of pruritus in patients with chronic liver disease: a multicenter study. Hepatol Res. 2018;48(3):E252–E262.
  • Montagnese S, Nsemi LM, Cazzagon N, et al. Sleep-wake profiles in patients with primary biliary cirrhosis. Liver Int. 2013;33(2):203–209.
  • Bergasa NV, Alling DW, Talbot T, et al. Effects of naloxone infusions in patients with the pruritus of cholestasis. A double-blind, randomized, controlled trial. Ann Intern Med. 1995;123(3):161–167.
  • Talwalkar JA, Souto E, Jorgensen RA, et al. Natural history of pruritus in primary biliary cirrhosis. Clin Gastroenterol Hepatol. 2003;1(4):297–302.
  • Raszeja-Wyszomirska J, Wunsch E, Krawczyk M, et al. Assessment of health related quality of life in polish patients with primary biliary cirrhosis. Clin Res Hepatol Gastroenterol. 2016;40(4):471–479.
  • Shah RA, Kowdley KV. Mechanisms and treatments of pruritus in primary biliary cholangitis. Semin Liver Dis. 2019;39(2):209–220.
  • Carrion AF, Rosen JD, Levy C. Understanding and treating pruritus in primary biliary cholangitis. Clin Liver Dis. 2018;22(3):517–532.
  • Zak A, Zeman M, Slaby A, et al. Xanthomas: clinical and pathophysiological relations. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158(2):181–188.
  • Schmidt HH, Manns MP. Images in hepatology. Regression of xanthelasmas in a patient with primary biliary cirrhosis after liver transplantation. J Hepatol. 1998;28(6):1077.
  • Dogra S, Jindal R. Cutaneous manifestations of common liver diseases. J Clin Exp Hepatol. 2011;1(3):177–184.
  • Rugivarodom M, Charatcharoenwitthaya P. Nontumoral portal vein thrombosis: a challenging consequence of liver cirrhosis. J Clin Transl Hepatol. 2020;28(8):432–444.
  • Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011;365(2):147–156.
  • Mammen EF. Coagulation defects in liver disease. Med Clin North Am. 1994;78(3):545–554.